Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
about
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathwayTargeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in CancerA critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistanceRole of the Drug Transporter ABCC3 in Breast Cancer ChemoresistanceChemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy.Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel.The multiple facets of drug resistance: one history, different approaches.Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cellsSecretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance.Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathwayABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1-MRP1) in the Polish populationCasein kinase 2α regulates multidrug resistance-associated protein 1 function via phosphorylation of Thr249.Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial CellsRegulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells.Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.Molecular profiling of head and neck squamous cell carcinoma.Development of purine-derived 18F-labeled pro-drug tracers for imaging of MRP1 activity with PET.Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy.Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation.MicroRNAs and drug resistance in prostate cancers.Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.Overcoming multidrug resistance with nanomedicines.Chemistry and Biology of Resveratrol-Derived Natural ProductsTransporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.MRP1 and its role in anticancer drug resistance.Nutrient restriction of glucose or serum results in similar proteomic expression changes in 3D colon cancer cell cultures.Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer.Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1.Simvastatin interacts synergistically with tipifarnib to induce apoptosis in leukemia cells through the disruption of RAS membrane localization and ERK pathway inhibition.miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats.Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia.Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.
P2860
Q24322825-90DAFCD1-6951-493D-886F-F1354F959117Q26741846-5FC7EBF1-F491-47CC-B188-329682669AB2Q28543175-0333FFB0-6354-4F1C-B42D-DAFE2A613FBBQ28552011-B9E53697-7986-4374-B998-6B9E2A90EB67Q30403036-D69950ED-F082-42A2-9F74-AB24E4025C12Q33490314-A966EEE9-6ACE-4CE8-92C8-72B258CAD432Q33657470-E73A84AF-93D0-4D62-9F2C-69D5F2289C2FQ33697116-9EFB9B0E-560D-47AF-AF75-6CB9D0B89B6EQ33895232-382D5F7B-4330-4926-ACBE-C09E3A61F68AQ34000586-351BC0BB-B884-4181-83D0-F3B7E5D319F0Q34204238-489CA0D3-8BDC-4AE3-ACF0-F03503D4ACACQ34465385-F34C9EBE-0F9E-4650-9049-F21482DD5A7BQ35067970-AF7D8E72-28FD-460C-9C55-0BCE9AD7E247Q35166695-3B2BE80A-DCAF-43BA-8FE8-573D81500596Q35784144-43A6738B-91AF-4143-A9AD-1881C4D41347Q36174733-14B9CCC9-A558-47A9-BD19-394FDEF78B67Q36876161-586D37D0-43C6-43F4-AD5F-AC8610EB4590Q37042612-A9C31BA0-BF2D-4A85-9879-3E098796F373Q37137009-48AA6AC4-E3B1-40A7-8E0D-02B59736AD3DQ37337359-103FEE8A-BA3B-40C1-B94C-E68CA0B745E5Q37658420-87751EE7-158A-4B96-B211-3B8AB4DCB7D2Q37665488-5D2925B0-2439-4C88-8803-6083879F6340Q37687390-1A90FBB6-CBDF-40CA-B797-928619FAA381Q37706632-3060CFA1-BB47-43D3-8558-0F178F04DA41Q38205266-F4980837-CCAE-4191-8C82-1B39970AC713Q38206278-2803FD91-0C45-4E47-907F-10D3829185F1Q38242231-B793709D-BFFC-46FE-BEFF-C58A3E7D1CC6Q38249954-29BF701C-7C0D-44EA-8EC2-EB5366C02555Q38401947-BBA4F90D-D372-41DA-B61B-1D8132E168A6Q38478413-9395412B-52AD-46F3-AF34-B61A581E4EB2Q38626237-A3642DA0-80A4-4DE8-9E6F-7523265C561AQ38730154-98C3C32B-E074-407F-8852-B7EFF27C38A8Q38837543-47D0F379-A604-43CF-A2DB-9C6CC927BC50Q38848383-4AB1ECF0-954D-4B7E-90EC-4E6F07AA0417Q38906160-5F8610F9-0B8C-4983-8679-CA96CB198523Q38952701-BC4AA62F-9C97-4408-90BB-E9890C0F58C6Q38972595-155C4892-B1F9-440A-AC25-F2DA46A0A5CBQ39018998-F744665C-CDE1-41A3-8009-AAB34A810B0EQ39224142-4D9D7599-3604-4978-8D13-1BFCDCC8DEF2Q39997697-F6E6818F-F2B8-4259-A282-4FE6EDEC3454
P2860
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@en
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@nl
type
label
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@en
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@nl
prefLabel
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@en
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@nl
P2093
P1433
P1476
Role of the MRP1/ABCC1 multidrug transporter protein in cancer.
@en
P2093
Marcia Munoz
Michelle Haber
Michelle Henderson
Murray Norris
P304
P356
10.1080/15216540701736285
P577
2007-12-01T00:00:00Z